
DermTech DMTK
Annual report 2023
added 02-29-2024
DermTech EV - Enterprise Value 2011-2026 | DMTK
Annual EV - Enterprise Value DermTech
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70.4 M | 109 M | 212 M | 758 M | 44.3 M | 47.2 M | 148 K | 128 K | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 758 M | 128 K | 155 M |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Biomerica
BMRA
|
6.63 M | $ 2.13 | - | $ 4.89 M | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
Lantheus Holdings
LNTH
|
5.9 B | $ 75.5 | -0.31 % | $ 5.1 B | ||
|
Aspira Women's Health
AWH
|
42.8 M | - | -6.19 % | $ 10.5 M | ||
|
Co-Diagnostics
CODX
|
29.3 M | $ 4.4 | 101.83 % | $ 129 M | ||
|
Medpace Holdings
MEDP
|
14 B | $ 455.28 | -0.36 % | $ 13.1 B | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
Mettler-Toledo International
MTD
|
32.1 B | $ 1 229.6 | -0.87 % | $ 25.3 B | ||
|
Charles River Laboratories International
CRL
|
11.4 B | $ 156.54 | -0.92 % | $ 7.76 B | ||
|
IQVIA Holdings
IQV
|
49.6 B | $ 165.42 | -0.95 % | $ 28.4 B | ||
|
Myriad Genetics
MYGN
|
598 M | $ 4.6 | -1.29 % | $ 426 M | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M | ||
|
BioNano Genomics
BNGO
|
34.1 M | $ 1.25 | -14.38 % | $ 6.81 M | ||
|
National Research Corporation
NRC
|
432 M | $ 17.47 | -0.26 % | $ 391 M | ||
|
Interpace Biosciences
IDXG
|
19.7 M | $ 1.71 | 0.73 % | $ 7.5 M | ||
|
IDEXX Laboratories
IDXX
|
52.7 B | $ 569.86 | -1.5 % | $ 45.8 B | ||
|
Illumina
ILMN
|
15.3 B | $ 122.99 | -0.65 % | $ 19.6 B | ||
|
ICON Public Limited Company
ICLR
|
26.4 B | $ 100.22 | -0.13 % | $ 8.27 B | ||
|
Guardant Health
GH
|
15.2 B | $ 84.35 | -0.65 % | $ 10.6 B | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | ||
|
Pacific Biosciences of California
PACB
|
1.21 B | $ 1.38 | -1.08 % | $ 414 M | ||
|
Celcuity
CELC
|
506 M | $ 103.02 | -3.49 % | $ 4.06 B | ||
|
Precipio
PRPO
|
10.9 M | $ 26.93 | - | $ 35 M | ||
|
Personalis
PSNL
|
229 M | $ 7.71 | 1.37 % | $ 457 M | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 263.52 | -0.36 % | $ 21.9 B | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
RadNet
RDNT
|
7.26 B | $ 60.39 | -2.19 % | $ 4.54 B | ||
|
ENDRA Life Sciences
NDRA
|
864 K | $ 3.41 | -2.16 % | $ 1.83 M | ||
|
NeoGenomics
NEO
|
1.85 B | $ 7.91 | -2.35 % | $ 1.01 B | ||
|
Agilent Technologies
A
|
45.8 B | $ 111.72 | -0.27 % | $ 34 B | ||
|
Natera
NTRA
|
5.53 B | $ 194.13 | -2.98 % | $ 19.1 B | ||
|
CareDx, Inc
CDNA
|
1.04 B | $ 17.24 | -1.82 % | $ 919 M | ||
|
OPKO Health
OPK
|
1.62 B | $ 1.14 | -0.88 % | $ 791 M | ||
|
Senseonics Holdings
SENS
|
376 M | $ 6.58 | -0.68 % | $ 275 M | ||
|
Castle Biosciences
CSTL
|
665 M | $ 25.84 | 0.35 % | $ 718 M | ||
|
Sotera Health Company
SHC
|
7.07 B | $ 13.77 | -0.79 % | $ 3.91 B | ||
|
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 194.57 | -0.54 % | $ 21.6 B | ||
|
DarioHealth Corp.
DRIO
|
11 M | $ 7.37 | -1.73 % | $ 29.4 M |